Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications

Leuk Res. 2013 Dec;37(12):1726-8. doi: 10.1016/j.leukres.2013.09.025. Epub 2013 Oct 8.

Abstract

Anaplastic multiple myeloma (AMM) is a rare morphologic variant of MM with adverse prognosis. The underlying molecular cytogenetic abnormalities are poorly understood. We investigated 11 patients with AMM for myeloma associated cytogenetic aberrations and compared with 188 non-anaplastic MM using fluorescent in situ hybridization. Of the 11 AMM patients studied, 10 had CKS1B amplification, 5 hemizygous 17p(p53) deletions, 4 13q14 deletions, 4 t(4:14), and 2 had t(11:14). AMM was associated with significantly higher prevalence of CKS1B amplification (91% vs. 34%, p<0.001), 17p(p53) deletion (45% vs. 11%, p=0.006) and t(4,14) (36% vs. 14%, p=0.015) than non-anaplastic MM, which may have resulted in the genetic instability and more aggressive clinical course.

Keywords: Anaplastic myeloma; CKS1B; FISH; Multiple myeloma; Prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • CDC2-CDC28 Kinases / genetics*
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 1 / genetics*
  • Cohort Studies
  • Female
  • Gene Amplification*
  • Gene Frequency
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / classification
  • Multiple Myeloma / epidemiology
  • Multiple Myeloma / genetics*

Substances

  • CKS1B protein, human
  • CDC2-CDC28 Kinases